In This Article:
April 21 - U.S. equity futures declined on Monday, as investors returned from the holiday weekend facing renewed concerns over U.S.-China trade tensions and a packed earnings calendar.
Nasdaq 100 futures slid about 1.2%, while Dow Jones Industrial Average and S&P 500 futures dropped nearly 0.9% and 1.1%, respectively. The three major indices also ended last week lower, notching their third loss in four weeks.
Weighing on sentiment was UnitedHealth (NYSE:UNH), which fell more than 22% on Thursday after cutting its full-year outlook and reporting underwhelming earnings. In contrast, Eli Lilly (NYSE:LLY) surged 14% following positive late-stage trial results for its experimental weight loss drug, orforglipron.
The ongoing lack of progress in direct U.S.-China trade talks, along with comments from Chicago Fed President Austan Goolsbee warning of potential economic slowdown from tariffs, added to the cautious tone.
Investors are bracing for key data releases this week, including durable goods orders and PMI readings, along with earnings from more than 100 S&P 500 firms. Notables include Alphabet (NASDAQ:GOOG), Tesla (NASDAQ:TSLA), Verizon (NYSE:VZ), and Procter & Gamble (NYSE:PG).
Meanwhile, the 10-year U.S. Treasury yield hovered near 4.36%, and WTI crude futures slipped toward $62.97 per barrel.
This article first appeared on GuruFocus.